论文部分内容阅读
近年来国内外文献陆续报道质子泵抑制剂加促胃肠动力药或胃粘膜保护剂治疗反流性食管炎(ＲＥ)有一定的疗效。但针对ＲＥ发病机制采用三联治疗的研究报告甚少 ,我们于２０００年６月～２００１年６月对ＲＥ患者使用质子泵抑制剂为主或Ｈ ２ 受体阻滞剂为主加用促胃肠动力药及胃?
In recent years, domestic and foreign literatures have reported proton pump inhibitors plus gastrointestinal motility drugs or gastric mucosal protective agent in the treatment of reflux esophagitis (RE) have a certain effect. But for the pathogenesis of RE triple therapy study reported very little, we in June 2000 ~ June 2001 RE patients with proton pump inhibitor or H 2 receptor blockers based plus gastrointestinal Power medicine and stomach?